MP54-18 THE ROLE OF PROPHYLACTIC ANTIBIOTICS AFTER LAPAROSCOPIC PYELOPLASTY WITH URETERAL STENT PLACEMENT IN CHILDREN

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Matthew Ferroni ◽  
Kevin Rycyna ◽  
Moira Dwyer ◽  
Francis Schneck ◽  
Michael Ost ◽  
...  
Keyword(s):  
Stent Placement ◽  
Prophylactic Antibiotics ◽  
Ureteral Stent ◽  
Laparoscopic Pyeloplasty

The Role of Prophylactic Antibiotics After Minimally Invasive Pyeloplasty With Ureteral Stent Placement in Children

Urology ◽  
2016 ◽  
Vol 89 ◽  
pp. 107-112 ◽  
Author(s):  
Matthew C. Ferroni ◽  
Timothy D. Lyon ◽  
Kevin J. Rycyna ◽  
Moira E. Dwyer ◽  
Francis X. Schneck ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Stent Placement ◽  
Prophylactic Antibiotics ◽  
Ureteral Stent

Intraoperative Retrograde Ureteral Stent Placement and Manipulation During Laparoscopic Pyeloplasty Without Need for Patient Repositioning

2010 ◽  
Vol 24 (10) ◽  
pp. 1571-1574 ◽  
Author(s):  
Davis P. Viprakasit ◽  
Hernan O. Altamar ◽  
Nicole L. Miller ◽  
S. Duke Herrell
Keyword(s):  
Stent Placement ◽  
Ureteral Stent ◽  
Laparoscopic Pyeloplasty

scholarly journals Role of Alfuzosin in Ureteral Stent Related Urinary Symptoms Score: A Comparative Study

2017 ◽  
Vol 10 (1) ◽  
pp. 28-30
Author(s):  
Santosh Shrestha ◽  
DB Adhikari ◽  
A Gurung ◽  
S Pradhan ◽  
NV Gurung ◽  
...  
Keyword(s):  
Comparative Study ◽  
Stent Placement ◽  
Flank Pain ◽  
Ureteral Stent ◽  
Urinary Symptoms ◽  
Control Group ◽  
Stent Insertion ◽  
Alpha Blockers

Background: Ureteral stent placement is a routine urological procedure. However, patients inserted with ureteral stent exhibited increased urinary symptoms that compromise patients’ quality of life.Objective: To assess the efficacy of alpha blockers (Alfuzosin) in the management of ureteral stent related urinary symptoms.Methods: Total of 60 patients after ureteral stent insertion was randomly divided into two equal groups; 30 in alfuzosin group and the remaining 30 in control group. Urinary symptoms questionnaire was filled after two weeks and results were statistically analyzed.Results: Urinary symptoms like urgency, frequency and flank pain were significantly less in the alfuzosin group when compared with control group.Conclusion: Alpha blocker (Alfuzosin) was found to be effective in reducing ureteral stent related urinary symptoms.Journal of Gandaki Medical CollegeVol. 10, No. 1, 2017, page: 28-30

scholarly journals Outcomes of ureteral stent placement for hydronephrosis in patients with ureteral stone

2021 ◽  
Vol 40 (3) ◽  
pp. 226-233
Author(s):  
Dyah Ratih Widyokirono ◽  
Yudhistira Pradnyan Kloping ◽  
Zakaria Aulia Rahman ◽  
Lukman Hakim
Keyword(s):  
Stent Placement ◽  
Prospective Observational Study ◽  
Ureteral Stone ◽  
Secondary Data ◽  
Ureteral Stent ◽  
Chi Square ◽  
Oral Medications ◽  
Stone Treatment ◽  
Baseline Characteristics

BackgroundRoutine ureteral stent placement after ureteroscopy (URS) for ureteral stone treatment is arguable due to the possible stent-related symptoms. Several studies claimed that its use is necessary, while others reported that its use is excessive. Hydronephrosis occurs when urine cannot drain out from the kidney to the bladder due to blockage or obstruction. We aimed to evaluate the role of ureteral stents in hydronephrosis resolution in ureteral stone patients following URS lithotripsy. MethodsThis was a prospective observational study using secondary data involving 130 ureteral stone patients undergoing URS lithotripsy [99 patients (76.2%) with stent placement and 31 patients (23.8%) without stent]. Data consisting of baseline characteristics, pre-operative status, intraoperative characteristics, and postoperative complications were collected from the medical record database and presented descriptively. The patients were divided into two groups based on stent placement. Comparison of hydronephrosis resolution between the groups was analyzed with Chi-square. ResultsUreteral lesions were the most common indication of ureteral stent placement following URS lithotripsy (28.3%). The most bothersome symptoms were dysuria in 18 patients (18.2%); followed by frequency in eight patients (8.1%) and low back pain in six patients (6.1%). All symptoms were successfully treated with oral medications. There were 41 patients (91.1%) with pre-operative hydronephrosis significantly resolved after stent placement compared to 5 (62.5%) patients without stent placement (p=0.027). ConclusionUreteral stenting significantly resolves pre-operative hydronephrosis after URS lithotripsy in patients with ureteral stone. Ureteral stent placement is the preferred method for the treatment of pre-operative hydronephrosis.

The Role of Ureteral Stent Placement in the Prevention of Steinstrasse

1999 ◽  
Vol 13 (3) ◽  
pp. 151-155 ◽  
Author(s):  
M.N. SULAIMAN ◽  
N.-P. BUCHHOLZ ◽  
P.B. CLARK
Keyword(s):  
Stent Placement ◽  
Ureteral Stent

The role of stent placement above the papilla (inside-stent) as a bridging therapy for perihilar biliary malignancy: an initial experience

Surgery Today ◽  
2021 ◽  
Author(s):  
Yu Takahashi ◽  
Naoki Sasahira ◽  
Takashi Sasaki ◽  
Yosuke Inoue ◽  
Yoshihiro Mise ◽  
...  
Keyword(s):  
Stent Placement ◽  
Initial Experience ◽  
Bridging Therapy ◽  
Biliary Malignancy

scholarly journals The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Xiao-Qin Liu ◽  
Xue-Yun Zhang ◽  
Yue Ying ◽  
Jian-Ming Zheng ◽  
Jian Sun ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Clinical Course ◽  
Prophylactic Antibiotics ◽  
Third Generation ◽  
Chronic Liver Failure ◽  
Free Survival ◽  
B Virus ◽  
Third Generation Cephalosporins

Abstract Background Acute-on-chronic liver failure (ACLF) is characterized by an excessive systemic inflammatory response and organ failure and has high mortality. Bacterial infections (BIs) worsen the clinical course of ACLF and carry a poor prognosis in ACLF patients. The efficacy of third-generation cephalosporins has been challenged in recent years. The aim of this study was to characterize the difference between ACLF patients with and without BIs and to provide a reference for medical intervention. Methods A total of 140 patients with hepatitis B virus-related ACLF (HBV-ACLF) hospitalized at the Department of Infectious Diseases, Huashan Hospital, Fudan University (Shanghai, China) between May 2013 and January 2020 were enrolled. Mann-Whitney U test was used to compare the baseline characteristics of HBV-ACLF patients with and without BIs. Univariate and multivariate analyses were performed to find predictors of BIs. The characteristics of BIs and the role of prophylactic antibiotics were profiled. Results A total of 97 episodes of BIs occurred in patients during the course of HBV-ACLF. Patients with and without BIs differed in clinical characteristics. The incidence of BIs showed a positive correlation with the ACLF grade (P = 0.003) and the clinical course (P = 0.003). The 90-day transplant-free survival of patients with BIs was lower than those without BIs (P < 0.0001). Patients administered prophylactic antibiotics showed a lower incidence of BIs and had a higher transplant-free survival probability than those who did not (P = 0.046). No statistical differences in antibiotic efficacy between third-generation and other antibiotics were observed (P = 0.108). Conclusions BIs affected the clinical course and prognosis of patients with HBV-ACLF. Prophylactic antibiotics were of potential clinical importance in the prevention of BIs and improving the clinical course and prognosis in HBV-ACLF patients. Third-generation cephalosporins were qualified for use in antibiotic prophylaxis.

Sign in / Sign up

Export Citation Format

Share Document